Cardinal Health earnings and US inflation data set the week’s market agenda

Cardinal Health earnings week ahead centres on two scheduled catalysts: July US inflation reports and the healthcare distributor’s fiscal fourth-quarter results. Consumer prices are due Wednesday, producer prices Thursday and Cardinal Health reports Tuesday morning, CNBC said in its preview of Aug. 10 to 14.

The releases arrive as investors assess inflation, the Federal Reserve’s policy stance and the latter stages of the second-quarter earnings season. CNBC also identified developments in the Iran war as a contextual market risk, after Treasury Secretary Scott Bessent said a deal could be approaching in the prior week but no such agreement emerged.

What are investors watching in the stock market this week?

The first major item is the July consumer price index, or CPI, followed by the producer price index, or PPI. CPI tracks prices paid by consumers. PPI measures prices received by producers at stages in the supply chain, making it a gauge investors may use to assess whether cost pressures could reach consumers later.

FactSet estimates cited by CNBC put headline CPI inflation at 3.4% year on year and core CPI at 2.5%. Core CPI excludes food and energy. For PPI, economists expected a 0.1% month-on-month rise in the headline measure and a 0.3% increase in the core reading.

Those figures may shape views on the outlook for monetary policy, though CNBC cautioned that their effect on markets could differ from past cycles. The outlet said the Federal Reserve is also weighing longer-term factors, including investment in AI data centres, alongside conventional economic readings. That is an interpretation of the policy backdrop rather than a confirmed forecast of the Fed’s next decision.

Other US data on the calendar include July existing-home sales on Tuesday and retail sales on Friday. CNBC characterised retail sales as the more consequential of the two for markets because it provides a current view of consumer spending.

What will Cardinal Health report?

Cardinal Health is scheduled to publish fiscal 2026 fourth-quarter results on Tuesday morning. The company distributes pharmaceuticals and medical supplies to hospitals and pharmacies, while also operating businesses in areas including specialty drugs and home delivery, CNBC said.

The central questions will be whether revenue and earnings exceed expectations after Cardinal’s revenue fell short in the previous quarter, and how management frames fiscal 2027. Guidance for the coming financial year could be particularly relevant because this report closes Cardinal’s fiscal 2026.

Peer results have set a reference point. Cencora and McKesson, which CNBC identified as Cardinal’s two main peers, both exceeded revenue and earnings expectations in the preceding week and lifted their full-year earnings guidance. Their specialty operations, including treatments in oncology and urology, were a noted area of strength, according to CNBC.

Investors will therefore have a compact sequence of potential signals: company guidance and housing data on Tuesday, consumer inflation on Wednesday, producer-price data on Thursday and a consumer-spending update on Friday. Any further verified progress toward an Iran-war agreement could add another variable to trading conditions.

This story draws on original reporting from CNBC.